[PWB] PowerShares Dynamic Lg.Cap Growth

Overview

Type of security: Fund

Tags: Active-Index, Country, Equity, ETF, Growth, Large-cap, Not Inversed, Stocks, U.S., Unleveraged

The data is delayed by 15 minutes.

 

Price: 32.31 Change: 0 (0%)

chart PWB

Refresh chart

Strongest Trends Summary For PWB

PWB is in the medium-term up 14% in 8 months. In the long-term up 19% in 2 years and up 90% in 6 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Large Cap Growth IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of large capitalization companies that comprise the Underlying Intellidex. NYSE Arca, Inc. considers a company to be a large capitalization company if it falls within the underlying intellidex model. The underlying intellidex for the fund is composed of 50 large capitalization U.S. growth stocks that the Intellidex Provider includes principally on the basis of their capital appreciation potential.

See how to gain 20% in 14 sec with TrendsInvesting

Technical Data
High 52 week35.24 Low 52 week29.79 Last close35.16 Last change-0.11%
RSI66.94 Average true range0.16 Beta0.96 Volume
Simple moving average 20 days0.93% Simple moving average 50 days1.92% Simple moving average 200 days7.71%
Performance Data
Performance Week0.23% Performance Month3.11% Performance Quart5.24% Performance Half11.65%
Performance Year13.84% Performance Year-to-date10.12% Volatility daily0.38% Volatility weekly0.86%
Volatility monthly1.76% Volatility yearly6.09% Relative Volume0% Average Volume40.87 K
New High New Low
Funds Characteristics
30-day SEC yield0.46 Average market capitalization Average weighted market capitalization Forward P/E
Gross expense ratio Index dividend yield Median market cap Number of holdings50
Price to Book Value 1.36 Price to Earnings22.64 Total expense ratio0.59% Total net assets
Weighted market capitalization86.21 B

Info

Characteristics:
NAME VALUE
Total Expense Ratio0,59
30 Day Sec Yield0,46
Number Of Holdings50
P/Bv Ratio1,36
P/E Ratio22,64
Weighted Market Capitalization86206
Top Holdings:
NAME VALUE
Berkshire Hathaway B3,69
Schlumberger3,58
Bank Of America3,56
Union Pacific3,56
United Parcel Service3,48
Walt Disney3,39
Honeywell International3,36
Home Depot3,3
Mastercard A3,29
Visa3,27
Nike B3,23
Google A3,14
Biogen Idec3,07
Priceline.com3,02
Gilead Sciences2,93
Energy Transfer Equity Lp1,57
Dish Network1,55
Vf1,55
Texas Instruments1,54
Eog Resources1,52
Halliburton1,51
Charles Schwab1,51
Te Connectivity1,51
Marsh Mclennan1,5
Td Ameritrade1,49
Morgan Stanley1,48
Tyco International1,47
Adp1,46
Mckesson1,46
Blackstone Group Lp1,46
Sector Breakdown:
NAME VALUE
Consumer Discretionary28,38
Consumer Staples2,85
Energy8,18
Financials16,09
Health Care12,77
Industrials14,74
Information Technology15,55
Materials1,43

News

2017-06-21 10:37:47 | Bristol-Myers Squibb Reported Revenue Growth in 1Q17

2017-06-02 10:36:33 | Performance of Eli Lilly’s Endocrine Products in 1Q17

2017-05-02 10:36:35 | Eli Lilly & Co.’s Developments in 1Q17

2017-04-20 12:55:00 | 4 Ways to Get Involved With Impact Investing

2017-03-31 10:36:14 | Exploring Eli Lilly’s Oncology Franchise in 2016

2017-03-17 07:38:01 | A Look at Opdivo’s Performance in 2016

2017-02-27 09:06:54 | Eli Lilly & Co.’s Oncology Franchise

2017-01-30 15:05:44 | Bristol-Myers Squibb’s Strong Oncology Segment

2017-01-26 10:36:17 | What to Expect from Eli Lilly’s Oncology Franchise in 4Q16

2017-01-18 09:55:02 | ETFs in Focus on Robust Q4 UnitedHealth Earnings

2016-11-28 08:04:29 | How Did Bristol-Myers Squibb’s Blockbuster Oncology Drug Perform?

2016-11-25 13:04:05 | How Did Bristol-Myers Squibb’s Oncology Segment Perform in 3Q16?

2016-11-24 08:04:18 | What You Should Know about Eli Lilly’s Oncology Franchise

2016-10-20 10:04:33 | Eli Lilly and Co.’s 3Q16 Estimates: Oncology Franchise

2016-10-19 10:01:02 | Buy UnitedHealth ETFs on Upbeat Q3 Earnings

2016-10-07 13:16:05 | Is the Dividend ETF Bull Run Over?

2016-10-05 09:42:00 | 3 ETFs to Buy for a Media Merger Frenzy

2016-09-19 08:04:40 | Roche Goes Up against Bristol-Myers Squibb in Oncology Drug Space

2016-09-02 11:04:23 | Eli Lilly’s Antidepressant and Schizophrenia Drug Sales Are Down

2016-09-01 11:04:32 | How Are Eli Lilly’s Business Segments Performing?

2016-08-24 10:04:05 | Why Did Hormel Foods Increase Its Fiscal 2016 Guidance?

2016-08-23 09:30:01 | The Zacks Analyst Blog Highlights: PureFunds ISE Junior Silver ETF, SPDR S&P Technology Hardware ETF, PowerShares Dynamic Semiconductors ETF, SPDR S&P Health Care Services ETF and PowerShares DWA Utilities Momentum ETF

2016-08-04 09:47:23 | Top Tech ETFs Of 2016

2016-07-27 11:57:25 | This Seasonal ETF Is Ripe For The Pickin' This Summer

2016-07-25 09:20:39 | A Consumer Staples ETF To Feast On

2016-07-23 12:00:00 | Restaurants Reflect Consumption Trends Literally

2016-07-12 17:05:06 | Why Are So Many Analysts Rating B&G Foods a ‘Hold’?

2016-06-29 10:59:33 | Why Did Cal-Maine Shares Fall 23% in the Last 3 Months?

2016-06-20 09:08:13 | Which Off-Price Retailer Is Operating at the Highest Margins?

2016-05-11 06:05:45 | Hain Celestial Traded above Key Moving Averages

2016-05-04 09:00:08 | Finding Pharmaceuticals ETFs With Rebound Potential

2016-04-28 09:08:14 | A Deeper Dive into March US Steel Imports Data

2016-03-31 17:24:57 | EMA Validates Opdivo’s Application for Additional Indications

2016-03-18 08:20:28 | Potent Value In This Large-Cap ETF

2016-03-09 06:37:00 | 5 Best Performing Bull Run Equity ETFs

2016-02-29 10:55:38 | A Close Look at B&G Foods’ Operating Margins in Fiscal 4Q15

2016-01-22 09:31:02 | 2 ETFs That Surged to Rank #1 Braving All Odds

2016-01-21 18:18:00 | Consumer Discretionary ETFs Rise But Starbucks Cools

2016-01-13 12:09:05 | Why Did the US Halt Bunge’s Canola Meal Shipment?